Clinical Trial Update: Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 4-week treatment with BIBW 2948 BS in chronic obstructive pulmonary disease with chronic bronchitis; the study has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BIBW 2948 BS

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic | Phase 2 | Status: WITHDRAWN